Hosted on MSN11mon
Bionomics to advance non-SSRI PTSD candidate to Phase III
Bionomics has announced plans to meet with the US Food & Drug Administration (FDA) in Q2 2024 following the release of positive topline data from a Phase IIb trial of its lead candidate BNC210 to ...
manilatimes2mon
Bionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM Evidence
Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to ...
JSTOR Daily4mon
Bionomics of the Bromeliad-Inhabiting Mosquito Wyeomyia vanduzeei and Its Nursery Plant Tillandsia utriculata
The Florida Entomologist, Vol. 64, No. 4 (Dec., 1981), pp. 491-506 (16 pages) Aquatic stages of the mosquito Wyeomyia vanduzeei Dyar & Knab inhabit leaf axils of the epiphytic bromeliad Tillandsia ...